Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will release second quarter 2022 financial results after the market closes on Wednesday, August 3, 2022. Xencor management will host a webcast and conference call the same day at … [Read more…]
